Tranfusion Facts Flashcards
FNHTR
1st/2nd most common
Cytokines
Leukoreduction
Leukoreduction pre/post storage
Post storage less effective but cheaper
TACO
Common
Slower infusion and diuretics
Most common cause of death
TRALI
Less than 6 hours from transfusion
Activation of neutrophils in lung
Ab to HLA (HNA less common)
1st hit of priming to TRALI (infection, cancer)
Neutropenia (relative)
Plasma multipara women is a risk factor
AHTR
ABO incompatibility
30% mortality
Pot transfusion purpura
Women that are HPA1A negative
Ab against HPA1A
7-10 days post transfusion
Tx IVIG Steroids
Prevention- HPA1A negative platelets
Bacterial contamination type in PLT
Gram positive in platelets
Hypocalcemia post transfusion
Citrate
Massive transfusion
Delayed hemolytic reaction prevention methods
Rh Kell matched blood mainly in pts requiring many blood transfusions or AIHA
Leukoreduction to reduce APC
reduce possibility for future ab
Blood group A carbohydrate
N-acetylgalactosamin
AcetylglacrosAmin
Blood group B carbohydrate
D-galactose
B=D
Galaxy B
Reasons of lack of natural antibodies to A,B
Neonates and elderly
Hypo/aglubolinemia
Reasons of excessive antibodies to A,B
Allo/auto-antibodies
Tx with non ABO matched plasma products
Paraprotein
Passenger Lymphocytes
Bombay phenotype blood
Lack of H antigen
resembles O but can receive only transfusions from Bombay donors
passenger lymphocyte syndrome
Lymphocytes of donor causing homolysis of pts RBCs
acquired B antigen
pts with group A
during infection with GNR
bacteria changes A to resmble B
But with no hemolysis
causing ABO discrepancy
Cells will not react with Anti-B serum
Weak D antigen
Qunatitive defects in D
all epitopes exist
donor and neonate must be classified as D+ bcs they can cause Ab developement in receipient
Blood receipient and pregnant women- considered D- bcs giving them D+ blood may cause Ab
Genentic tesiting available
Partial D variant
Loss of antigens on D (Qualititive)
common in blacks
Discovered when D+ pts develop Ab
No rutine way to diagnose
Ab development % to minor blood types depending on disease
30% in SCD, Thalasemia and AIHA
0% in ALL
Leukoreductionof blood products benefit
FNHTR
CMV
alloimmunization to HLA (PLT refractoriness)
Irradiation of blood product benefit
GVHD
Washing of blood product benefit
Allergic reactions